Caribou Biosciences Inc (NASDAQ:CRBU) price on Wednesday, December 04, fall -6.22% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.04.
A look at the stock’s price movement, the close in the last trading session was $2.17, moving within a range at $2.0215 and $2.17. The beta value (5-Year monthly) was 2.263. Turning to its 52-week performance, $8.33 and $1.50 were the 52-week high and 52-week low respectively. Overall, CRBU moved -13.03% over the past month.
Caribou Biosciences Inc’s market cap currently stands at around $184.28 million, with investors looking forward to this quarter’s earnings report slated for in January.
The average forecast suggests down to a -48.20% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 9.13M, representing a -73.51% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CRBU is a Hold. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend CRBU as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CRBU’s current price about -8.66% and -1.23% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 45.99, while 7-day volatility ratio is 8.88% and 11.00% in the 30-day chart. Further, Caribou Biosciences Inc (CRBU) has a beta value of 2.27, and an average true range (ATR) of 0.21. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $3. Looking at the price targets, the low is -47.06% off current price level while to achieve the yearly target high, price needs to move -47.06%. Nonetheless, investors will most likely welcome a -47.06% jump to $3 which is the analysts’ median price.
If we refocus on Caribou Biosciences Inc (NASDAQ:CRBU), historical trading data shows that trading volumes averaged 1.64 over the past 10 days and 1.28 million over the past 3 months. The company’s latest data on shares outstanding shows there are 90.55 million shares.
The 12.58% of Caribou Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 58.66% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.42 million on 2024-11-15, giving us a short ratio of 4.78. The data shows that as of 2024-11-15 short interest in Caribou Biosciences Inc (CRBU) stood at 858.0 of shares outstanding, with shares short falling to 11.51 million registered in 2024-10-15. Current price change has pushed the stock -64.49% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CRBU stock continues to rise going into the next quarter.
